Deep Dive: Deep Dive Into Oral Oncolytics

Shereen Stutz and Mark Alwardt of McKesson discuss how the rise in oral oncolytics during the COVID-19 pandemic allowed pharmacies to be more innovative and to become an even more integrated part of the oncology care team.